7575.Two
7575.TWO is a medical equipment and supplies company that generates revenue primarily through the distribution and sale of healthcare products and services.
Business. 7575.TWO is a medical equipment and supplies company that generates revenue primarily through the distribution and sale of healthcare products and services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
7575.TWO is a medical equipment and supplies company that generates revenue primarily through the distribution and sale of healthcare products and services.
The company's capital structure is characterized by a debt-to-equity ratio of 1.27, indicating a moderate reliance on debt financing. With a market cap of 592.5 million TWD and an enterprise value to revenue ratio of 1.34, the company appears to be valued at a relatively low multiple compared to its revenue. The liquidity position is assessed as medium, with a negative net cash position after subtracting total debt.
In terms of profitability, the company reported an operating cash flow of 18.88 million TWD, which is relatively low compared to its total liabilities of 744.6 million TWD. The return on invested capital (ROIC) and other profitability metrics are not provided, but the company's operating cash flow suggests limited capacity to service its debt obligations. The company's financial performance is expected to remain stable, with no significant changes in revenue or profitability anticipated in the near term.
The company's revenue is concentrated in the healthcare services and equipment sector, with no specific geographic breakdown provided. The lack of geographic diversification may expose the company to regional economic and regulatory risks. The company's exposure to specific segments is not detailed, but its primary business activity is in the distribution and sale of medical equipment and supplies.
The company's growth trajectory is expected to remain modest, with no significant revenue growth projected in the current or next fiscal year. The company's capital expenditure of -27.14 million TWD indicates a reduction in investment in physical assets, which may affect its long-term growth potential. The company's financial performance is expected to remain stable, with no significant changes in revenue or profitability anticipated in the near term.
The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio of 1.27 suggests a moderate reliance on debt financing, which may increase its financial risk in the event of economic downturns. The company's negative net cash position after subtracting total debt indicates a potential liquidity constraint. The company's risk assessment does not indicate any significant dilution potential, suggesting that the company is not likely to issue additional shares in the near term.
Recent events and filings do not provide specific details on the company's operations or financial performance. The company's financial snapshot indicates a stable but modest financial position, with no significant changes in revenue or profitability anticipated in the near term. The company's risk assessment suggests that it is not likely to face significant financial or operational risks in the near term.
- The company has a debt-to-equity ratio of 1.27, indicating a moderate reliance on debt financing.
- The company's enterprise value to revenue ratio of 1.34 suggests a relatively low valuation compared to its revenue.
- The company's liquidity position is assessed as medium, with a negative net cash position after subtracting total debt.
- The company's operating cash flow of 18.88 million TWD is relatively low compared to its total liabilities of 744.6 million TWD.
- The company's growth trajectory is expected to remain modest, with no significant revenue growth projected in the current or next fiscal year.
- The company's risk profile is characterized by a medium liquidity risk and a low dilution risk.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- 7575.TWO Market data — financials · 2026-05-27